Target intelligence / Profile preview

Hydroxyapatite (HAP) (HAP)

Target
HAP
Molecular classification
Inorganic mineral, Calcium phosphate, Other
01

Overview

Tooth enamel and dentin are primarily composed of hydroxyapatite [Ca10(PO4)6(OH)2], a crystalline calcium phosphate mineral that provides the structural hardness necessary for mastication (PubChem CID 14781). In the oral environment, this mineral undergoes constant cycles of demineralization and remineralization influenced by bacterial acids and salivary buffers (NIH/NIDCR). When demineralization exceeds remineralization, dental caries and erosion occur, leading to the loss of tooth structure. Therapeutic interventions target this mineral substrate to promote the deposition of new mineral or the conversion of hydroxyapatite into fluorapatite [Ca10(PO4)6F2] (Journal of Dental Research). Fluorapatite is significantly more resistant to acid-induced dissolution than the original hydroxyapatite, thereby enhancing the tooth's defense against decay (StatPearls). Modern treatments utilize fluoride, nano-hydroxyapatite, and calcium-phosphate complexes to stabilize the mineral surface and occlude exposed dentinal tubules (PubMed). This target is unique in that it involves the chemical modification of a biological crystal rather than the modulation of a protein or signaling pathway.

Other names
Tooth mineralCarbonated hydroxyapatiteDental enamel mineralDentin mineralCalcium hydroxyapatite
02

Mechanism of action

Promotion of remineralization through ion deposition and the substitution of hydroxyl groups with fluoride ions to form acid-resistant fluorapatite.

03

Biological functions

Structural supportAcid resistanceIon reservoirOther
04

Disease associations

Dental cariesDentin hypersensitivityEnamel erosionInfectionOther
05

Safety considerations

Dental fluorosisSkeletal fluorosisSilver stainingAbrasivity
06

Interacting drugs

Sodium fluoride

4 more in the full profile.

07

Biomarkers

Mineral densitySurface microhardnessLesion depthSalivary calcium/phosphate ratio

Beyond the preview

Go deeper on Hydroxyapatite (HAP) (HAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxyapatite (HAP) (HAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call